Revisiting Buruli ulcer

Journal of Dermatology

Volumn 42, Issue 11, 2015, Pages 1033-1041

  Yotsu, Rie R ^a,b   Murase, Chiaki ^c   Sugawara, Mariko ^d   Suzuki, Koichi ^e,f   Nakanaga, Kazue ^f   Ishii, Norihisa ^f   Asiedu, Kingsley ^g  

^a National Suruga Sanatorium   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d West Yokohama Sugawara Dermatology Clinic   (Japan)

^e TEIKYO UNIVERSITY   (Japan)

^f NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Buruli ulcer; Mycobacterium ulcerans; mycolactone; neglected tropical diseases; non tuberculous mycobacteria

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BURULI ULCER; CLINICAL FEATURE; COLONY FORMATION; DEBRIDEMENT; DIRECT SMEAR; DISEASE TRANSMISSION; EDEMA; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFLAMMATION; LABORATORY TEST; MYCOBACTERIUM ULCERANS; NONHUMAN; PAPULE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; REVIEW; SKIN DISEASE; SKIN PLAQUE; SKIN SWELLING; SKIN TRANSPLANTATION; STAMP TEST; SUBCUTANEOUS NODULE; TROPICS; COMMUNICABLE DISEASES, EMERGING; NEGLECTED DISEASES;

BURULI ULCER; COMMUNICABLE DISEASES, EMERGING; HUMANS; NEGLECTED DISEASES;

EID: 84946491783     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.13049     Document Type: Review

References (83)

1. Alsop DG,. The bairnsdale ulcer. Aust N Z J Surg 1972; 41: 317-319.
2. MacCallum P, Tolhurst JC, Buckle G, Sissons HA,. A new mycobacterial infection in man. J Pathol Bacteriol 1948; 60: 93-122.
3. Fenner F,. The significance of the incubation period in infectious diseases. Med J Aust 1950; 2: 813-818.
4. Nakanaga K, Hoshino Y, Yotsu RR, Makino M, Ishii N,. Nineteen cases of Buruli ulcer diagnosed in Japan from 1980 to 2010. J Clin Microbiol 2011; 49: 3829-3836.
5. Yotsu RR, Nakanaga K, Hoshino Y, Suzuki K, Ishii N,. Buruli ulcer and current situation in Japan: a new emerging cutaneous Mycobacterium infection. J Dermatol 2012; 39: 587-593.
6. Qi W, Kaser M, Roltgen K, Yeboah-Manu D, Pluschke G,. Genomic diversity and evolution of Mycobacterium ulcerans revealed by next-generation sequencing. PLoS Pathog 2009; 5: e1000580.
7. Ortiz RH, Leon DA, Estevez HO, et al,. Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas. Clin Exp Immunol 2009; 157: 271-281.
8. Kaser M, Rondini S, Naegeli M, et al,. Evolution of two distinct phylogenetic lineages of the emerging human pathogen Mycobacterium ulcerans. BMC Evol Biol 2007; 7: 177.
9. World Health Organization. Global Health Obse rvatory (GHO) data: Buruli ulcer. 2015; http://www.who.int/gho/neglected-diseases/buruli-ulcer/en/. Accessed 4 April 2015.
10. van der Werf TS, van der Graaf WT, Groothuis DG, Knell AJ,. Mycobacterium ulcerans infection in Ashanti region, Ghana. Trans R Soc Trop Med Hyg 1989; 83: 410-413.
11. Marston BJ, Diallo MO, Horsburgh CR Jr, et al,. Emergence of buruli ulcer disease in the daloa region of cote d'Ivoire. Am J Trop Med Hyg 1995; 52: 219-224.
12. Debacker M, Aguiar J, Steunou C, et al,. Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health 2004; 9: 1297-1304.
13. Quek TY, Athan E, Henry MJ, et al,. Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerg Infect Dis 2007; 13: 1661-1666.
14. Lavender CJ, Fyfe JA, Azuolas J, et al,. Risk of Buruli ulcer and detection of Mycobacterium ulcerans in mosquitoes in southeastern Australia. PLoS Negl Trop Dis 2011; 5: e1305.
15. Wallace JR, Gordon MC, Hartsell L, et al,. Interaction of Mycobacterium ulcerans with mosquito species: implications for transmission and trophic relationships. Appl Environ Microbiol 2010; 76: 6215-6222.
16. Luo Y, Degang Y, Ohtsuka M, Ishido Y, Ishii N, Suzuki K,. Detection of Mycobacterium ulcerans subsp. shinshuense DNA from a water channel in familial Buruli ulcer cases in Japan. Future Microbiol 2015; 10: 461-469.
17. Sugawara M, Ishii N, Nakanaa K, et al,. Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan. J Dermatol 2015; 42: 581-595.
18. Stinear TP, Mve-Obiang A, Small PL, et al,. Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci U S A 2004; 101: 1345-1349.
19. Stinear TP, Pryor MJ, Porter JL, Cole ST,. Functional analysis and annotation of the virulence plasmid pMUM001 from Mycobacterium ulcerans. Microbiology 2005; 151: 683-692.
20. Stinear TP, Seemann T, Pidot S, et al,. Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res 2007; 17: 192-200.
21. Stinear TP, Seemann T, Harrison PF, et al,. Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res 2008; 18: 729-741.
22. Nakanaga K, Yotsu RR, Hoshino Y, Suzuki K, Makino M, Ishii N,. Buruli ulcer and mycolactone-producing mycobacteria. Jpn J Infect Dis 2013; 66: 83-88.
23. Yip MJ, Porter JL, Fyfe JA, et al,. Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor. J Bacteriol 2007; 189: 2021-2029.
24. Roltgen K, Stinear TP, Pluschke G,. The genome, evolution and diversity of Mycobacterium ulcerans. Infect Genet Evol 2012; 12: 522-529.
25. Stragier P, Ablordey A, Bayonne LM, et al,. Heterogeneity among Mycobacterium ulcerans isolates from Africa. Emerg Infect Dis 2006; 12: 844-847.
26. Doig KD, Holt KE, Fyfe JA, et al,. On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer. BMC Genom 2012; 13: 258.
27. George KM, Chatterjee D, Gunawardana G, et al,. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 1999; 283: 854-857.
28. Scherr N, Gersbach P, Dangy JP, et al,. Structure-activity relationship studies on the macrolide exotoxin mycolactone of Mycobacterium ulcerans. PLoS Negl Trop Dis 2013; 7: e2143.
29. Coutanceau E, Decalf J, Martino A, et al,. Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone. J Exp Med 2007; 204: 1395-1403.
30. Simmonds RE, Lali FV, Smallie T, et al,. Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism. J Immunol 2009; 182: 2194-2202.
31. Boulkroun S, Guenin-Mace L, Thoulouze MI, et al,. Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events. J Immunol 2010; 184: 1436-1444.
32. George KM, Pascopella L, Welty DM, Small PL,. A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun 2000; 68: 877-883.
33. Marion E, Song OR, Christophe T, et al,. Mycobacterial toxin induces analgesia in buruli ulcer by targeting the Angiotensin pathways. Cell 2014; 157: 1565-1576.
34. Suzuki K, Akama T, Kawashima A, et al,. Current status of leprosy: epidemiology, basic science and clinical perspectives. J Dermatol 2012; 39: 121-129.
35. Hall B, Simmonds R,. Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer. Biochem Soc Trans 2014; 42: 177-183.
36. Eddyani M, Fraga AG, Schmitt F, et al,. Fine-needle aspiration, an efficient sampling technique for bacteriological diagnosis of nonulcerative Buruli ulcer. J Clin Microbiol 2009; 47: 1700-1704.
37. Eddyani M, Debacker M, Martin A, et al,. Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semisolid transport medium. J Clin Microbiol 2008; 46: 69-72.
38. Bratschi MW, Bolz M, Grize L, et al,. Primary cultivation: factors affecting contamination and Mycobacterium ulcerans growth after long turnover time of clinical specimens. BMC Infect Dis 2014; 14: 636.
39. Converse PJ, Xing Y, Kim KH, et al,. Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease. PLoS Negl Trop Dis 2014; 8: e2618.
40. Affolabi D, Bankole H, Ablordey A, et al,. Effects of grinding surgical tissue specimens and smear staining methods on Buruli ulcer microscopic diagnosis. Trop Med Int Health 2008; 13: 187-190.
41. Herbinger KH, Adjei O, Awua-Boateng NY, et al,. Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin Infect Dis 2009; 48: 1055-1064.
42. Phillips RO, Sarfo FS, Osei-Sarpong F, et al,. Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer. J Clin Microbiol 2009; 47: 924-926.
43. Ross BC, Marino L, Oppedisano F, Edwards R, Robins-Browne RM, Johnson PD,. Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol 1997; 35: 1696-1700.
44. Stinear T, Ross BC, Davies JK, et al,. Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. J Clin Microbiol 1999; 37: 1018-1023.
45. Portaels F, ed. Laboratory diagnosis of Buruli ulcer: A manual for health care providers. Geneva, Swizterland: World Health Organization, 2014.
46. Fyfe JA, Lavender CJ, Johnson PD, et al,. Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol 2007; 73: 4733-4740.
47. Lavender CJ, Fyfe JA,. Direct detection of Mycobacterium ulcerans in clinical specimens and environmental samples. Methods Mol Biol 2013; 943: 201-216.
48. Njiru ZK, Yeboah-Manu D, Stinear TP, Fyfe JA,. Rapid and sensitive detection of Mycobacterium ulcerans by use of a loop-mediated isothermal amplification test. J Clin Microbiol 2012; 50: 1737-1741.
49. Ablordey A, Amissah DA, Aboagye IF, et al,. Detection of Mycobacterium ulcerans by the loop mediated isothermal amplification method. PLoS Negl Trop Dis 2012; 6: e1590.
50. World Health Organization. Treatment of Mycobacterium ulcerans disease (Buruli ulcer). Geneva, Switzerland: World Health Organization, 2012.
51. Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). World Health Organization 2004. WHO.CDS/CPE/GBII.10.
52. Klis S, Stienstra Y, Phillips RO, Abass KM, Tuah W, van der Werf TS,. Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial. PLoS Negl Trop Dis 2014; 8: e2739.
53. O'Brien DP, Jenkin G, Buntine J, et al,. Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update. Med J Aust 2014; 200: 267-270.
54. Takahashi T, Fujimoto N, Nakanishi G, Ishii N, Tanaka T,. Mapping biopsy procedure on management of severe buruli ulcer due to Mycobacterium ulcerans subspecies shinshuense. JAMA Dermatol 2014; 150: 669-671.
55. Nienhuis WA, Stienstra Y, Abass KM, et al,. Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection. Clin Infect Dis 2012; 54: 519-526.
56. Ruf MT, Chauty A, Adeye A, et al,. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection? PLoS Negl Trop Dis 2011; 5: e1252.
57. Aiga H, Amano T, Cairncross S, Adomako J, Nanas OK, Coleman S,. Assessing water-related risk factors for Buruli ulcer: a case-control study in Ghana. Am J Trop Med Hyg 2004; 71: 387-392.
58. Pouillot R, Matias G, Wondje CM, et al,. Risk factors for buruli ulcer: a case control study in Cameroon. PLoS Negl Trop Dis 2007; 1: e101.
59. Raghunathan PL, Whitney EA, Asamoa K, et al,. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana. Clin Infect Dis 2005; 40: 1445-1453.
60. Debacker M, Portaels F, Aguiar J, et al,. Risk factors for Buruli ulcer, Benin. Emerg Infect Dis 2006; 12: 1325-1331.
61. Brou T, Broutin H, Elguero E, Asse H, Guegan JF,. Landscape diversity related to Buruli ulcer disease in Cote d'Ivoire. PLoS Negl Trop Dis 2008; 2: e271.
62. Meyers WM, Shelly WM, Connor DH, Meyers EK,. Human Mycobacterium ulcerans infections developing at sites of trauma to skin. Am J Trop Med Hyg 1974; 23: 919-923.
63. Tanghe A, Adnet PY, Gartner T, Huygen K,. A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice. Infect Immun 2007; 75: 2642-2644.
64. Portaels F, Aguiar J, Debacker M, et al,. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect Immun 2004; 72: 62-65.
65. Portaels F, Aguiar J, Debacker M, et al,. Prophylactic Effect of Mycobacterium bovis BCG Vaccination against Osteomyelitis in Children with Mycobacterium ulcerans Disease (Buruli Ulcer). Clin Diagn Lab Immunol 2002; 9: 1389-1391.
66. BCG vaccination against mycobacterium ulcerans infection (Buruli ulcer). First results of a trial in Uganda. Lancet 1969; 1: 111-115.
67. Nackers F, Dramaix M, Johnson RC, et al,. BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin. Am J Trop Med Hyg 2006; 75: 768-774.
68. Smith PG, Revill WD, Lukwago E, Rykushin YP,. The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda. Trans R Soc Trop Med Hyg 1976; 70: 449-457.
69. Marsollier L, Andre JP, Frigui W, et al,. Early trafficking events of Mycobacterium ulcerans within Naucoris cimicoides. Cell Microbiol 2007; 9: 347-355.
70. Mosi L, Williamson H, Wallace JR, Merritt RW, Small PL,. Persistent association of Mycobacterium ulcerans with West African predaceous insects of the family belostomatidae. Appl Environ Microbiol 2008; 74: 7036-7042.
71. Portaels F, Meyers WM, Ablordey A, et al,. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis 2008; 2: e178.
72. Williamson HR, Benbow ME, Nguyen KD, et al,. Distribution of Mycobacterium ulcerans in buruli ulcer endemic and non-endemic aquatic sites in Ghana. PLoS Negl Trop Dis 2008; 2: e205.
73. Marion E, Eyangoh S, Yeramian E, et al,. Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis 2010; 4: e731.
74. Marsollier L, Severin T, Aubry J, et al,. Aquatic snails, passive hosts of Mycobacterium ulcerans. Appl Environ Microbiol 2004; 70: 6296-6298.
75. Elsner L, Wayne J, O'Brien CR, et al,. Localised Mycobacterium ulcerans infection in a cat in Australia. J Feline Med Surg 2008; 10: 407-412.
76. Eddyani M, Ofori-Adjei D, Teugels G, et al,. Potential role for fish in transmission of Mycobacterium ulcerans disease (Buruli ulcer): an environmental study. Appl Environ Microbiol 2004; 70: 5679-5681.
77. Kotlowski R, Martin A, Ablordey A, Chemlal K, Fonteyne PA, Portaels F,. One-tube cell lysis and DNA extraction procedure for PCR-based detection of Mycobacterium ulcerans in aquatic insects, molluscs and fish. J Med Microbiol 2004; 53: 927-933.
78. Sakaguchi K, Iima H, Hirayama K, et al,. Mycobacterium ulcerans infection in an Indian flap-shelled turtle (Lissemys punctata punctata). J Vet Med Sci 2011; 73: 1217-1220.
79. Fyfe JA, Lavender CJ, Handasyde KA, et al,. A major role for mammals in the ecology of Mycobacterium ulcerans. PLoS Negl Trop Dis 2010; 4: e791.
80. Mitchell PJ, Jerrett IV, Slee KJ,. Skin ulcers caused by Mycobacterium ulcerans in koalas near Bairnsdale, Australia. Pathology 1984; 16: 256-260.
81. van Zyl A, Daniel J, Wayne J, et al,. Mycobacterium ulcerans infections in two horses in south-eastern Australia. Aust Vet J 2010; 88: 101-106.
82. Ross BC, Johnson PD, Oppedisano F, et al,. Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease. Appl Environ Microbiol 1997; 63: 4135-4138.
83. Stinear T, Davies JK, Jenkin GA, Hayman JA, Oppedisano F, Johnson PD,. Identification of Mycobacterium ulcerans in the environment from regions in Southeast Australia in which it is endemic with sequence capture-PCR. Appl Environ Microbiol 2000; 66: 3206-3213.